AWKNFAwakn Life Sciences Corp.

About Awakn Life Sciences Corp. (AWKNF)

Awakn Life Sciences Corp. (AWKNF) is a Biotechnology company headquartered in Toronto, ON, Canada whose shares trade over-the-counter on the Pink tier.

Awakn Life Sciences Corp. is a clinical-stage biotechnology company developing therapeutics targeting substance use and mental health disorders. Awakn has a near-term focus on AUD , a condition affecting approximately 29 million adults in the US and approximately 40 million in the US and key European markets for which the current standard of care is inadequate. Our goal is to provide breakthrough therapeutics to addiction sufferers in desperate need and our strategy is focused on commercialising our R&D pipeline across multiple channels.

Products and services

Awakn Life Sciences Corp. is a clinical-stage biotechnology company developing therapeutics targeting substance use and mental health disorders. Awakn has a near-term focus on AUD , a condition affecting approximately 29 million adults in the US and approximately 40 million in the US and key European markets for which the current standard of care is inadequate. Our goal is to provide breakthrough therapeutics to addiction sufferers in desperate need and our strategy is focused on commercialising our R&D pipeline across multiple channels.

AWKNF key facts

Ticker symbol

AWKNF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Toronto, ON, Canada

Country of incorporation

CA

Year of incorporation

2018

Employees

7

Estimated market cap

$2.92M (as of Dec 13, 2024)

Shares outstanding

42,922,623

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

1/31

Latest filing

Interim Financial Report (Oct 31, 2024)

Awakn Life Sciences Corp. leadership

• Anthony Tennyson — CEO
• Jonathan Held — CFO
• David Nutt — Other

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with A